Los Angeles Capital Management’s Aerie Pharmaceuticals, Inc. AERI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-116,560
| Closed | -$1.76M | – | 1309 |
|
|
2022
Q3 | $1.76M | Buy |
116,560
+71,907
| +161% | +$1.09M | 0.01% | 530 |
|
|
2022
Q2 | $335K | Sell |
44,653
-140
| -0.3% | -$1.05K | ﹤0.01% | 1109 |
|
|
2022
Q1 | $408K | Buy |
+44,793
| New | +$408K | ﹤0.01% | 1114 |
|
|
2021
Q1 | – | Sell |
-15,885
| Closed | -$215K | – | 1677 |
|
|
2020
Q4 | $215K | Sell |
15,885
-125
| -0.8% | -$1.69K | ﹤0.01% | 1456 |
|
|
2020
Q3 | $188K | Hold |
16,010
| – | – | ﹤0.01% | 1399 |
|
|
2020
Q2 | $236K | Buy |
+16,010
| New | +$236K | ﹤0.01% | 1355 |
|
|
2019
Q3 | – | Sell |
-15,157
| Closed | -$448K | – | 1400 |
|
|
2019
Q2 | $448K | Hold |
15,157
| – | – | ﹤0.01% | 1076 |
|
|
2019
Q1 | $720K | Buy |
+15,157
| New | +$720K | ﹤0.01% | 974 |
|
|
2018
Q4 | – | Sell |
-8,360
| Closed | -$515K | – | 1416 |
|
|
2018
Q3 | $515K | Sell |
8,360
-7,070
| -46% | -$436K | ﹤0.01% | 1085 |
|
|
2018
Q2 | $1.04M | Buy |
15,430
+2,140
| +16% | +$145K | 0.01% | 882 |
|
|
2018
Q1 | $721K | Buy |
+13,290
| New | +$721K | ﹤0.01% | 922 |
|
|
2017
Q4 | – | Sell |
-5,670
| Closed | -$276K | – | 1417 |
|
|
2017
Q3 | $276K | Buy |
+5,670
| New | +$276K | ﹤0.01% | 1173 |
|